The introduction and evaluation of patient-clinician email communication in Merseyside clinical genetics service

ISRCTN ISRCTN18421278
DOI https://doi.org/10.1186/ISRCTN18421278
Secondary identifying numbers N0128162659
Submission date
29/09/2006
Registration date
29/09/2006
Last edited
08/09/2015
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Other
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Emma McCann
Scientific

c/o Royal Liverpool Children's Hospital
Eaton Road
Liverpool
L12 2AP
United Kingdom

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeOther
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleThe introduction and evaluation of patient-clinician email communication in Merseyside clinical genetics service
Study objectivesDoes email communication have a role in the patient-clinician relationship in clinical genetics? Would patients, who present to the clinical genetics team, use email to communicate with the department?
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedEmail communication in patient-clinician relationship
InterventionRandomised controlled trial. Intervention group: email address and telephone number. Control group: telephone number only.

Patients will be identified and invited to take part in the study at two separate points in the referral pathway:
1. At the home visit by a genetic counsellor.
2. At the clinic visit by a clinical geneticist and/or Dr Emma McCann.
Intervention typeOther
Primary outcome measureComparison of "email and telephone" group with "telephone" group only. Is there a difference in the proportions contacting the department? Assess number of contacts per person.
Secondary outcome measuresNot provided at time of registration
Overall study start date20/04/2005
Completion date20/10/2006

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants120 participants in total (60 per arm)
Key inclusion criteria1. Referral to clinical genetics
2. Over 16 years of age or the parent/guardian of children under 16 years of age
3. With access to email
Key exclusion criteriaPatients attending for prenatal counselling or predictive testing.
Date of first enrolment20/04/2005
Date of final enrolment20/10/2006

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

c/o Royal Liverpool Children's Hospital
Liverpool
L12 2AP
United Kingdom

Sponsor information

Record Provided by the NHSTCT Register - 2006 Update - Department of Health
Government

The Department of Health, Richmond House, 79 Whitehall
London
SW1A 2NL
United Kingdom

Phone +44 (0)20 7307 2622
Email dhmail@doh.gsi.org.uk
Website http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Hospital/treatment centre

Liverpool Women's Hospital NHS Trust (UK)

No information available

NHS R&D Support Funding (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan